LATS2 and neoplasm: No known oncogenes were found mutated, but four of the seven patients (GIST_150, _174, _124 and _188) showed deleterious mutations in two candidates (KEAP1 and LATS2) and in three well-known tumor suppressors (CDKN2A, CDKN1B and PTEN).